Innovation Pharmaceuticals Inc (IPIX)

[baytdr]

Current treatments for people with IBD tend to focus on decreasing or altering immune function but defining which organisms are pro-inflammatory and which ones are anti-inflammatory is important as it could potentially lead to a treatment that wipes out the pro-inflammatory ones and repopulates the intestines with anti-inflammatory ones and studies also indicate that fungus may also play a role in the condition. Brilacidin as a therapy for IBD seems to me to be at the epicenter of where current research is focused and initial results look very promising. It seems obvious that both antibiotics and probiotics would both have a place in helping restore a healthy microbiota.